William C. Timmer, PhD
Dr. William Timmer joined CGCB as a Program Director (Health Science Administrator) in September 2007. His principal effort is directed toward management of a portfolio of clinical oncology research grants (principally involving brain, head and neck, lung, liver, colorectal, pancreatic and sarcoma cancers) within CTEP. He is also the NCI Program Director for the Adult Brain Tumor Consortium.
Dr. Timmer received his PhD in Chemistry from the University of Wisconsin, and he immediately began his federal career at the NIH. He studied the immunoregulatory effects of cytokines on HIV replication in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases. He subsequently joined the Food and Drug Administration where, over a fifteen year period, he held a variety of scientific and regulatory positions of increasing influence in three different FDA Centers: Foods, Drugs, and Biologics. At the Centers for Drugs and Biologics, Dr. Timmer evaluated regulatory submissions in the areas of HIV detection kits, cellular and gene therapies, medical devices and several currently-marketed oncology drugs.
Dr. Timmer has over 50 publications and presentations to his credit. He has received numerous honor awards from both the NIH and the FDA, and has recently completed twenty-seven years of federal service.
About the Branch Chief
Vikram Devgan, Ph.D., MBA. joined the National Cancer Institute in 2016 as a Chief of Clinical Grants and Contracts Branch of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis. From 2006 to 2016, Dr. Devgan held positions of increasing responsibilities with QIAGEN Inc., rising to Head of the Center of Excellence for Biological Research Content. More…